Imperial Brands, the global tobacco and nicotine business, today announces the acquisition of a range of nicotine pouches from TJP Labs in order to facilitate its entry into the US modern oral market.
The transaction will enable ITG Brands, Imperial’s US operation, to offer legal adult American consumers a diverse range of 14 product variants in a pouch which performs strongly in consumer testing.
Following further consumer testing, ITG Brands will relaunch this range in 2024 under a new brand, which will be supported by the company’s existing US sales force.
TJP Labs, a Canada-based manufacturer, will continue to manufacture the oral nicotine pouches under contract for ITG Brands.
Stefan Bomhard, Group CEO of Imperial Brands, said: “Today’s transaction is aligned to our focused, challenger approach in next generation products and to our disciplined capital allocation framework.
“While it will take time to build our presence in this category, the proposition we are acquiring is clearly differentiated within the US market and has tested strongly with consumers.”
Kim Reed, President and CEO of ITG Brands, said: “This is an opportunity to expand our next generation product offerings in the US and to be able to offer our legal adult consumers a wider range of product options. We look forward to a long and successful partnership with TJP Labs.”
David Richmond-Peck, CEO of TJP Labs, said: “Imperial has extensive brand development, marketing and sales execution capabilities in the US and a long global track record of operating responsibly. We look forward to a strong and ongoing partnership.
“This transaction supports TJP Labs' commitment to developing and producing products to promote global harm reduction, consumer choice and flexibility.”
The transaction – for an initial consideration of £65 million, with an additional deferred sum based on sales volumes over five years – is consistent with Imperial’s capital allocation policy to invest in the business strategy through small bolt-on transactions. The company continues to be committed to an ongoing multi-year share buyback.
Imperial already markets modern oral products in selected European markets under the Zone X and Skruf brands.
| Investor Contacts | Media Contacts | ||
| Peter Durman | +44 (0)7970 328 903 | Jonathan Oliver | +44 (0)7740 096 018 |
| Jennifer Ramsey | +44 (0)7974 615 739 | Simon Evans | +44 (0)7967 467 684 |
| Henry Dodd | +44 (0)7941 648 421 | Alexandra Wich | +1 (202)740 7390 |
Notes:
About Imperial Brands
Imperial Brands plc, a FTSE 100 company headquartered in the UK, is a global consumer goods organisation and the fourth largest international tobacco company.
Our core tobacco business is built around a comprehensive portfolio of local and international cigarette brands and other tobacco products and smoking accessories available in 120 markets worldwide.
Aligned with our purpose to forge a path to a healthier future for moments of relaxation and pleasure, we are also committed to building a sustainable next generation product (NGP) business, offering smokers a targeted range of potentially less harmful alternatives to traditional tobacco products. For more information visit imperialbrandsplc.com.
About ITG Brands
ITG Brands is America’s third-largest tobacco company and a member of the globally recognized Imperial Brands PLC family. We are part of a rich heritage of winning in the marketplace through forward thinking and operational integrity. ITG Brands is proud to offer some of the best-known cigarette, cigar and vape products in the world. For more information visit itgbrands.com.
About TJP Labs
TJP Labs Inc is North America's leading full-service contract manufacturer of premier next generation products, focusing on modern oral nicotine pouches and oral delivery solutions for caffeine and other nutraceutical products. For more information visit tjplabs.com.
